Editorial: Resolution of inflammation: Mechanisms, mediators and biomarkers: Volume II

Front Pharmacol. 2022 Nov 24:13:1100420. doi: 10.3389/fphar.2022.1100420. eCollection 2022.

Paola Patrignani¹, Bernhard Brüne^{2

3}, Dieter Steinhilber^{3

4}

¹ Department of Neuroscience, Imaging and Clinical Science, School of Medicine and CAST, G d'Annunzio University, Chieti, Italy.
² Institute of Biochemistry I, Faculty of Medicine, Goethe University, Frankfurt, Germany.
³ Fraunhofer Institute for Translational Medicine and Pharmacology, ITMP and Fraunhofer Cluster of Excellence for Immune Mediated diseases, CIMD, Frankfurt, Germany.
⁴ Institute of Pharmaceutical Chemistry, Goethe University, Frankfurt, Germany.

No abstract available

Keywords: CD40; NASH; SPM; lipoxygenase; resolution of inflammation; resveratrol; sphingolipids.

Publication types